Galderma Group AG - Registered Shares

0
CHIX:GALDz (Switzerland)   Registered Shares
CHF 83.97 (+2.38%) Nov 8
465.81
P/B:
2.90
Market Cap:
CHF 19.81B ($ 22.58B)
Enterprise V:
CHF 22.04B ($ 25.13B)
Volume:
24.98K
Avg Vol (2M):
51.51K
Trade In:
Volume:
24.98K
Avg Vol (2M):
51.51K

Business Description

Galderma Group AG

ISIN : CH1335392721

Share Class Description:

CHIX:GALDz: Registered Shares
Compare
Compare
Traded in other countries / regions
GALD.SwitzerlandGALDz.UKGALDY.USAPY30.Germany
IPO Date
2024-04-02
Description
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset 0.61
Debt-to-Equity 0.39
Debt-to-EBITDA 6.36
Interest Coverage 1.3
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 70.48
9-Day RSI 66.81
14-Day RSI 63.68
6-1 Month Momentum % 7.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.2
Quick Ratio 0.92
Cash Ratio 0.26
Days Inventory 226.55
Days Sales Outstanding 150.88
Days Payable 358.98

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2024-11-11 Est.)

CHIX:GALDz's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Galderma Group AG Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 1,980.661
EPS (TTM) (CHF) 0.179
Beta 0
Volatility % 0
14-Day RSI 63.68
14-Day ATR (CHF) 1.996523
20-Day SMA (CHF) 80.7695
12-1 Month Momentum % 0
52-Week Range (CHF) 61.57 - 85.77
Shares Outstanding (Mil) 237.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Galderma Group AG Filings

Filing Date Document Date Form
No Filing Data

Galderma Group AG Stock Events

Financials Calendars
Event Date Price(CHF)
No Event Data

Galderma Group AG Frequently Asked Questions

What is Galderma Group AG(CHIX:GALDz)'s stock price today?
The current price of CHIX:GALDz is CHF83.97. The 52 week high of CHIX:GALDz is CHF85.77 and 52 week low is CHF61.57.
When is next earnings date of Galderma Group AG(CHIX:GALDz)?
The next earnings date of Galderma Group AG(CHIX:GALDz) is 2024-11-11 Est..
Does Galderma Group AG(CHIX:GALDz) pay dividends? If so, how much?
Galderma Group AG(CHIX:GALDz) does not pay dividend.

Press Release

Subject Date
No Press Release